Sort   by:  
 Page size 
TranscriptomicsIsolation and in vitro expansion of human colonic stem cells [Expression profile]
Using the surface marker EPHB2, we have FACS-purified and profiled stem cell-enriched cell fractions from normal human mucosa, crypt proliferative progenitors and late transient amplifying cells to define a gene expression program specific for normal human colon epithelial stem cells We FACS purifie...
ORGANISM(S): Homo sapiens 
2011-11-22 | E-GEOD-31255 | biostudies-arrayexpress
MetabolomicsGeographic variation of mutagenic exposures in kidney cancer genomes

International differences in the incidence of many cancer types indicate the existence of carcinogen exposures that have not been identified by conventional epidemiology yet potentially make a substantial contribution to cancer burden1. This pertains to clear cell renal cell carcinoma (ccRCC), fo...

2024-03-26 | MTBLS9394 | MetaboLights
UnknownAge- and Gender-related Disparities in Primary Percutaneous Coronary Interventions for Acute ST-segment elevation Myocardial Infarction.
Not available
S-EPMC4564139 | biostudies-literature
UnknownEffectiveness of automated appointment reminders in psychosis community services: a randomised controlled trial.
Not available
S-EPMC6020281 | biostudies-literature
UnknownA Phase III Randomized Controlled Trial of Plitidepsin, a Marine-Derived Compound, in Hospitalized Adults With Moderate COVID-19.
Not available
S-EPMC11478586 | biostudies-literature
Unknownβ-catenin activity induces an RNA biosynthesis program promoting therapy resistance in T Acute Lymphoblastic Leukemia
Not available
S-SCDT-10_15252-EMMM_202216554 | biostudies-other
UnknownPreventive strategies and factors associated with surgically treated necrotising enterocolitis in extremely preterm infants: an international unit survey linked with retrospective cohort data analysis.
Not available
S-EPMC6797308 | biostudies-literature
UnknownIκB kinase- coordinates BRD4 and JAK/STAT signaling to subvert DNA damage-based anti-cancer therapy
Not available
S-SCDT-10_15252-EMBJ_2023114719 | biostudies-other
UnknownINOVATYON/ ENGOT-ov5 study: Randomized phase III international study comparing trabectedin/pegylated liposomal doxorubicin (PLD) followed by platinum at progression vs carboplatin/PLD in patients with recurrent ovarian cancer progressing within 6-12 months after last platinum line.
Not available
S-EPMC10070417 | biostudies-literature
UnknownMortality after surgery in Europe: a 7 day cohort study.
Not available
S-EPMC3493988 | biostudies-literature
Sort   by:  
 Page size